Literature DB >> 11019717

Acute lung injury and acute respiratory distress syndrome. The clinical syndrome.

K P Steinberg1, L D Hudson.   

Abstract

Acute lung injury (ALI) is a syndrome of severe acute respiratory failure defined by a constellation of clinical criteria. The exact incidence of ALI is not known, but it generally occurs in the setting of acute severe illness. The course of ALI after onset is quite variable, but outcome is associated with risk factor, age, and comorbidity. Survival from this syndrome has improved over time. Survivors often are impaired after hospital discharge but tend to improve over time; however, ALI does confer a significant additional burden on survivors with regard to pulmonary function and health-related quality of life.

Entities:  

Mesh:

Year:  2000        PMID: 11019717     DOI: 10.1016/s0272-5231(05)70156-8

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  8 in total

Review 1.  The pulmonary physician in critical care. 5: Acute lung injury and the acute respiratory distress syndrome: definitions and epidemiology.

Authors:  K Atabai; M A Matthay
Journal:  Thorax       Date:  2002-05       Impact factor: 9.139

2.  Time course of metabolic activity and cellular infiltration in a murine model of acid-induced lung injury.

Authors:  Vanessa Zambelli; Giuseppe Di Grigoli; Margherita Scanziani; Silvia Valtorta; Maria Amigoni; Sara Belloli; Cristina Messa; Antonio Pesenti; Ferruccio Fazio; Giacomo Bellani; Rosa Maria Moresco
Journal:  Intensive Care Med       Date:  2012-01-26       Impact factor: 17.440

3.  A randomized trial of recombinant human granulocyte-macrophage colony stimulating factor for patients with acute lung injury.

Authors:  Robert Paine; Theodore J Standiford; Ronald E Dechert; Marc Moss; Gregory S Martin; Andrew L Rosenberg; Victor J Thannickal; Ellen L Burnham; Morton B Brown; Robert C Hyzy
Journal:  Crit Care Med       Date:  2012-01       Impact factor: 7.598

4.  Adenovirus-mediated overexpression of soluble ST2 provides a protective effect on lipopolysaccharide-induced acute lung injury in mice.

Authors:  H Yin; X Y Li; B H Yuan; B B Zhang; S L Hu; H B Gu; X B Jin; J Y Zhu
Journal:  Clin Exp Immunol       Date:  2011-02-24       Impact factor: 4.330

5.  Severe delayed pulmonary toxicity following PD-L1-specific CAR-T cell therapy for non-small cell lung cancer.

Authors:  Heping Liu; Yuxiang Ma; Chaopin Yang; Shangzhou Xia; Qiuzhong Pan; Hongyun Zhao; Wenfeng Fang; Xi Chen; Yang Zhang; Benyan Zou; Qiuyuan Li; Yang Wan; Hao Chen; Yan Tang; Jingjing Zhao; Desheng Weng; Liming Xia; Li Zhang; Jianchuan Xia
Journal:  Clin Transl Immunology       Date:  2020-10-09

6.  Basiliximab induced non-cardiogenic pulmonary edema in two pediatric renal transplant recipients.

Authors:  Niamh Dolan; Mary Waldron; Marie O'Connell; Nick Eustace; Kevin Carson; Atif Awan
Journal:  Pediatr Nephrol       Date:  2009-08-01       Impact factor: 3.714

7.  Surfactant lavage with lidocaine improves pulmonary function in piglets after HCl-induced acute lung injury.

Authors:  T K Huang; C F T Uyehara; V Balaraman; C Y Miyasato; D Person; E Egan; D Easa
Journal:  Lung       Date:  2004       Impact factor: 2.584

8.  Deletion of caveolin-1 protects against oxidative lung injury via up-regulation of heme oxygenase-1.

Authors:  Yang Jin; Hong Pyo Kim; Minli Chi; Emeka Ifedigbo; Stefan W Ryter; Augustine M K Choi
Journal:  Am J Respir Cell Mol Biol       Date:  2008-03-06       Impact factor: 6.914

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.